The DOI matches its Crossref record; 295 of the 295 references it cites were found in a registry or an index.
Oral delivery of anticancer drugs: Challenges and opportunities
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Biodegradable polymeric nanoparticles based drug delivery systems
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.09.001 · Cited by 3,724
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Chitosan Chemistry and Pharmaceutical Perspectives
Kumar, M. N. V. R., Muzzarelli, R. A. A., Muzzarelli, C., Sashiwa, H., & Domb, A. J. (2004) · Chemical Reviews · doi:10.1021/cr030441b · Cited by 2,938
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., & Gottesman, M. M. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.361 · Cited by 2,059
Nanoparticle PEGylation for Imaging and Therapy
Jokerst, J. V., Lobovkina, T., Zare, R. N., & Gambhir, S. S. (2011) · Nanomedicine · doi:10.2217/nnm.11.19 · Cited by 2,046
Cyclodextrin-based pharmaceutics: past, present and future
Davis, M. E., & Brewster, M. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1576 · Cited by 1,996
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
Encyclopedia of Pharmaceutical Technology
Swarbrick, J. (2013) · CRC Press eBooks · doi:10.1201/b19309 · Cited by 1,794
Yin Win, K., & Feng, S.-S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.050 · Cited by 1,452
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
Neslihan Gursoy, R., & Benita, S. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.02.001 · Cited by 1,358
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Malam, Y., Loizidou, M., & Seifalian, A. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.004 · Cited by 1,318
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
Polymeric micelles—A new generation of colloidal drug carriers
Jones, M.-C., & Leroux, J.-C. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00039-9 · Cited by 1,256
Yee, S. (1997) · Pharmaceutical Research · doi:10.1023/a:1012102522787 · Cited by 1,030
Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability?
Brouwers, J., Brewster, M. E., & Augustijns, P. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21650 · Cited by 947
Coombes, R., Kilburn, L., Snowdon, C., Paridaens, R., Coleman, R., Jones, S., Jassem, J., Van de Velde, C., Delozier, T., Alvarez, I., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60200-1 · Cited by 907
Cellular Cholesterol Efflux Mediated by Cyclodextrins
Kilsdonk, E. P. C., Yancey, P. G., Stoudt, G. W., Bangerter, F. W., Johnson, W. J., Phillips, M. C., & Rothblat, G. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17250 · Cited by 890
Sparreboom, A., van Asperen, J., Mayer, U., Schinkel, A. H., Smit, J. W., Meijer, D. K. F., Borst, P., Nooijen, W. J., Beijnen, J. H., & van Tellingen, O. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2031 · Cited by 882
Targeted delivery of low molecular drugs using chitosan and its derivatives
Park, J. H., Saravanakumar, G., Kim, K., & Kwon, I. C. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.003 · Cited by 821
Shegokar, R., & Müller, R. H. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.044 · Cited by 740
Enhancing intestinal drug solubilisation using lipid-based delivery systems
Porter, C. J. H., Pouton, C. W., Cuine, J. F., & Charman, W. N. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.014 · Cited by 690
Oral drug absorption enhancement by chitosan and its derivatives
Thanou, M., Verhoef, J. C., & Junginger, H. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00231-9 · Cited by 689
Clinical Pharmacokinetics of Imatinib
Peng, B., Lloyd, P., & Schran, H. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544090-00001 · Cited by 665
Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery
van Vlerken, L. E., Vyas, T. K., & Amiji, M. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9284-6 · Cited by 645
Nano-emulsions and Micro-emulsions: Clarifications of the Critical Differences
Anton, N., & Vandamme, T. F. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0309-1 · Cited by 621
Polymer–drug conjugation, recent achievements and general strategies
Pasut, G., & Veronese, F. M. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.008 · Cited by 616
Lipid nanocapsules: A new platform for nanomedicine
Huynh, N. T., Passirani, C., Saulnier, P., & Benoit, J. P. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.026 · Cited by 595
Importance of P-glycoprotein at blood–tissue barriers
Fromm, M. F. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.06.002 · Cited by 592
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 2: Mechanism of Absorption Enhancement
Schipper, N. G. M., Olsson, S., Hoogstraate, J. A., deBoer, A. G., Vårum, K. M., & Artursson, P. (1997) · Pharmaceutical Research · doi:10.1023/a:1012160102740 · Cited by 586
Adherence to Therapy With Oral Antineoplastic Agents
Partridge, A. H. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.9.652 · Cited by 584
A Novel Phase Inversion-Based Process for the Preparation of Lipid Nanocarriers
Heurtault, B., Saulnier, P., Pech, B., Proust, J.-E., & Benoit, J.-P. (2002) · Pharmaceutical Research · doi:10.1023/a:1016121319668 · Cited by 583
Patient adherence and persistence with oral anticancer treatment
Ruddy, K., Mayer, E., & Partridge, A. (2009) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20004 · Cited by 569
Brannon-Peppas, L. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00324-x · Cited by 528
Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers
Rege, B. D., Kao, J. P. Y., & Polli, J. E. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00055-6 · Cited by 509
Ganta, S., & Amiji, M. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800240j · Cited by 490
Regulation of PTP1B via Glutathionylation of the Active Site Cysteine 215
Barrett, W. C., DeGnore, J. P., König, S., Fales, H. M., Keng, Y.-F., Zhang, Z.-Y., Yim, M. B., & Chock, P. B. (1999) · Biochemistry · doi:10.1021/bi990240v · Cited by 488
Dendrimers in Oncology: An Expanding Horizon
Tekade, R. K., Kumar, P. V., & Jain, N. K. (2009) · Chemical Reviews · doi:10.1021/cr068212n · Cited by 466
Dendrimers as Drug Carriers: Applications in Different Routes of Drug Administration
Cheng, Y., Xu, Z., Ma, M., & Xu, T. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21079 · Cited by 452
Improving the Oral Bioavailability of Curcumin Using Novel Organogel-Based Nanoemulsions
Yu, H., & Huang, Q. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf300609p · Cited by 429
P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement
Varma, M. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00158-0 · Cited by 418
Lipid – An emerging platform for oral delivery of drugs with poor bioavailability
Chakraborty, S., Shukla, D., Mishra, B., & Singh, S. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.06.001 · Cited by 411
Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs
Dong, Y., & Feng, S.-S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.03.021 · Cited by 395
Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery
Muchow, M., Maincent, P., & Müller, R. H. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802130061 · Cited by 394
Borchard, G., Lueβen, H. L., de Boer, A. G., Verhoef, J. C., Lehr, C.-M., & Junginger, H. E. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00146-8 · Cited by 393
Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms
Tang, B., Cheng, G., Gu, J.-C., & Xu, C.-H. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.04.006 · Cited by 393
Polymeric micelles for oral drug delivery
Gaucher, G., Satturwar, P., Jones, M.-C., Furtos, A., & Leroux, J.-C. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.06.007 · Cited by 389
Deli, M. A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.09.016 · Cited by 385
Schipper, N. G. M., Vårum, K. M., & Artursson, P. (1996) · Pharmaceutical Research · doi:10.1023/a:1016444808000 · Cited by 384
Influence of molecular weight on oral absorption of water soluble chitosans
Chae, S. Y., Jang, M.-K., & Nah, J.-W. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.012 · Cited by 383
Ottmann, O., Dombret, H., Martinelli, G., Simonsson, B., Guilhot, F., Larson, R. A., Rege-Cambrin, G., Radich, J., Hochhaus, A., Apanovitch, A. M., et al. (2007) · Blood · doi:10.1182/blood-2007-02-073528 · Cited by 366
Gao, P., Rush, B. D., Pfund, W. P., Huang, T., Bauer, J. M., Morozowich, W., Kuo, M., & Hageman, M. J. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10511 · Cited by 361
Varma, M. V. S., & Panchagnula, R. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.04.003 · Cited by 361
Wu, C.-Y., Benet, L. Z., Hebert, M. F., Gupta, S. K., Rowland, M., Gomez, D. Y., & Wacher, V. J. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90168-x · Cited by 356
Wong, H. L., Bendayan, R., Rauth, A. M., Xue, H. Y., Babakhanian, K., & Wu, X. Y. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101154 · Cited by 344
PEGylated PLGA nanoparticles for the improved delivery of doxorubicin
Park, J., Fong, P. M., Lu, J., Russell, K. S., Booth, C. J., Saltzman, W. M., & Fahmy, T. M. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.02.002 · Cited by 339
SEZGIN, Z., YUKSEL, N., & BAYKARA, T. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.06.003 · Cited by 332
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination
Garinot, M., Fiévez, V., Pourcelle, V., Stoffelbach, F., des Rieux, A., Plapied, L., Theate, I., Freichels, H., Jérôme, C., Marchand-Brynaert, J., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.021 · Cited by 331
Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration
Yang, S., Zhu, J., Lu, Y., Liang, B., & Yang, C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018888927852 · Cited by 324
Roger, E., Lagarce, F., Garcion, E., & Benoit, J.-P. (2010) · Nanomedicine · doi:10.2217/nnm.09.110 · Cited by 324
Breedveld, P., Beijnen, J. H., & Schellens, J. H. M. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.009 · Cited by 323
Fate of polymeric nanocarriers for oral drug delivery
Plapied, L., Duhem, N., des Rieux, A., & Préat, V. (2011) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2010.12.005 · Cited by 320
Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction
Thummel, K. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00039-2 · Cited by 318
Transepithelial transport and toxicity of PAMAM dendrimers: Implications for oral drug delivery
Sadekar, S., & Ghandehari, H. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.010 · Cited by 311
Evidence that tyrosine phosphorylation may increase tight junction permeability
Staddon, J. M., Herrenknecht, K., Smales, C., & Rubin, L. L. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.2.609 · Cited by 310
Feng, S.-S., Mei, L., Anitha, P., Gan, C. W., & Zhou, W. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.045 · Cited by 306
Yin, Y.-M., Cui, F.-D., Mu, C.-F., Choi, M.-K., Kim, J. S., Chung, S.-J., Shim, C.-K., & Kim, D.-D. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.015 · Cited by 304
Hunter, J., & Hirst, B. H. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00497-3 · Cited by 291
Gastrointestinal absorption of drugs: methods and studies
Barthe, L., Woodley, J., & Houin, G. (1999) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.1999.tb00334.x · Cited by 290
Kolhatkar, R. B., Kitchens, K. M., Swaan, P. W., & Ghandehari, H. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0603889 · Cited by 287
Clinical Pharmacokinetics of Irinotecan
Chabot, G. G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733040-00001 · Cited by 282
Solid lipid nanoparticles: an oral bioavailability enhancer vehicle
Harde, H., Das, M., & Jain, S. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.604311 · Cited by 281
Self-citationCollnot, E.-M., Baldes, C., Wempe, M. F., Kappl, R., Hüttermann, J., Hyatt, J. A., Edgar, K. J., Schaefer, U. F., & Lehr, C.-M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060121r · Cited by 280
P-Glycoprotein Increases from Proximal to Distal Regions of Human Small Intestine
Mouly, S., & Paine, M. F. (2003) · Pharmaceutical Research · doi:10.1023/a:1026183200740 · Cited by 276
YUAN, H., MIAO, J., DU, Y., YOU, J., HU, F., & ZENG, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.012 · Cited by 275
Peltier, S., Oger, J.-M., Lagarce, F., Couet, W., & Benoît, J.-P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0022-2 · Cited by 274
Development of Farnesyl Transferase Inhibitors: A Review
Appels, N. M. G. M., Beijnen, J. H., & Schellens, J. H. M. (2005) · The Oncologist · doi:10.1634/theoncologist.10-8-565 · Cited by 272
Oral cancer treatment: developments in chemotherapy and beyond
O'Neill, V. J., & Twelves, C. J. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600591 · Cited by 269
Roger, E., Lagarce, F., Garcion, E., & Benoit, J.-P. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.010 · Cited by 265
Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs
van Leeuwen, R. W. F., Brundel, D. H. S., Neef, C., van Gelder, T., Mathijssen, R. H. J., Burger, D. M., & Jansman, F. G. A. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.48 · Cited by 264
Targeted drug conjugates: principles and progress
Garnett, M. C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00227-7 · Cited by 262
Engineering of Dendrimer Surfaces to Enhance Transepithelial Transport and Reduce Cytotoxicity
Jevprasesphant, R., Penny, J., Attwood, D., McKeown, N. B., & D'Emanuele, A. (2003) · Pharmaceutical Research · doi:10.1023/a:1026166729873 · Cited by 256
Membrane Topology of a Cysteine-less Mutant of Human P-glycoprotein
Loo, T. W., & Clarke, D. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.843 · Cited by 252
Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers
El-Sayed, M., Ginski, M., Rhodes, C., & Ghandehari, H. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00087-1 · Cited by 251
Graham, J., Muhsin, M., & Kirkpatrick, P. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1287 · Cited by 251
Azathioprine, 6-mercaptopurine in inflammatory bowel disease: Pharmacology, efficacy, and safety
Dubinsky, M. C. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00344-1 · Cited by 249
Kalaria, D. R., Sharma, G., Beniwal, V., & Ravi Kumar, M. N. V. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9763-4 · Cited by 246
Nagasaki, Y., Okada, T., Scholz, C., Iijima, M., Kato, M., & Kataoka, K. (1998) · Macromolecules · doi:10.1021/ma971294k · Cited by 245
Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems
Bernkop-Schnürch, A. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.05.001 · Cited by 244
Weiss, M. J., Wong, J. R., Ha, C. S., Bleday, R., Salem, R. R., Steele, G. D., & Chen, L. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5444 · Cited by 240
Wiwattanapatapee, R., Carreño-Gómez, B., Malik, N., & Duncan, R. (2000) · Pharmaceutical Research · doi:10.1023/a:1007587523543 · Cited by 234
von Pawel, J., Gatzemeier, U., Pujol, J.-L., Moreau, L., Bildat, S., Ranson, M., Richardson, G., Steppert, C., Rivière, A., Camlett, I., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1743 · Cited by 234
Lo, Y.-L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00163-9 · Cited by 233
Jain, A. K., Swarnakar, N. K., Godugu, C., Singh, R. P., & Jain, S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.037 · Cited by 232
Self-citationQuercetin: A potential drug to reverse multidrug resistance
Chen, C., Zhou, J., & Ji, C. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.07.004 · Cited by 232
Sha, X., Yan, G., Wu, Y., Li, J., & Fang, X. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.01.001 · Cited by 231
Nanotechnology for Molecular Imaging and Targeted Therapy
Wickline, S. A., & Lanza, G. M. (2003) · Circulation · doi:10.1161/01.cir.0000059651.17045.77 · Cited by 226
Entropy-induced dispersion of bulk liquids
Reiss, H. R. (1975) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(75)90035-1 · Cited by 220
Makhey, V. D., Guo, A., Norris, D. A., Hu, P., Yan, J., & Sinko, P. J. (1998) · Pharmaceutical Research · doi:10.1023/a:1011971303880 · Cited by 215
Gao, P., Guyton, M. E., Huang, T., Bauer, J. M., Stefanski, K. J., & Lu, Q. (2004) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120028718 · Cited by 208
Lee, S. C., Huh, K. M., Lee, J., Cho, Y. W., Galinsky, R. E., & Park, K. (2007) · Biomacromolecules · doi:10.1021/bm060307b · Cited by 206
Choi, J.-S., Piao, Y.-J., & Kang, K. W. (2011) · Archives of Pharmacal Research · doi:10.1007/s12272-011-0411-x · Cited by 206
Coadministration of oral cyclosporin A enables oral therapy with paclitaxel.
Terwogt, J. M. M., Malingré, M. M., Beijnen, J. H., Huinink, W. W. T. B., Rosing, H., Koopman, F. J., van Tellingen, O., Swart, M., & Schellens, J. H. M. (1999) · PubMed · Cited by 205
Garrigues, A., Escargueil, A. E., & Orlowski, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162366399 · Cited by 201
Dabholkar, R. D., Sawant, R. M., Mongayt, D. A., Devarajan, P. V., & Torchilin, V. P. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.018 · Cited by 200
Allen, J. D., Brinkhuis, R. F., van Deemter, L., Wijnholds, J., & Schinkel, A. H. (2000) · PubMed · Cited by 200
Coadministration of Cyclosporine Strongly Enhances the Oral Bioavailability of Docetaxel
Malingré, M. M., Richel, D. J., Beijnen, J. H., Rosing, H., Koopman, F. J., Ten Bokkel Huinink, W. W., Schot, M. E., & Schellens, J. H. M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.1160 · Cited by 199
The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles
Mo, R., Jin, X., Li, N., Ju, C., Sun, M., Zhang, C., & Ping, Q. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.005 · Cited by 198
Natural and Synthetic Polymers as Inhibitors of Drug Efflux Pumps
Werle, M. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9347-8 · Cited by 197
Johnson, B. M., Charman, W. N., & Porter, C. J. H. (2002) · AAPS PharmSci · doi:10.1208/ps040440 · Cited by 193
Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs
Takeuchi, H., Matsui, Y., Sugihara, H., Yamamoto, H., & Kawashima, Y. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.06.028 · Cited by 190
Optimization of 5-fluorouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer
Yassin, A. E. B., Anwer, M. K., Mowafy, H. A., El-Bagory, I. M., Bayomi, M. A., & Alsarra, I. A. (2010) · International Journal of Medical Sciences · doi:10.7150/ijms.7.398 · Cited by 188
Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel
Jain, S., Kumar, D., Swarnakar, N. K., & Thanki, K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.026 · Cited by 188
Self-citationLectin-bearing Polymerized Liposomes as Potential Oral Vaccine Carriers
Chen, H., Torchilin, V., & Langer, R. (1996) · Pharmaceutical Research · doi:10.1023/a:1016030202104 · Cited by 186
Zhigaltsev, I. V., Maurer, N., Akhong, Q.-F., Leone, R., Leng, E., Wang, J., Semple, S. C., & Cullis, P. R. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.01.010 · Cited by 186
Breast Cancer Resistance Protein and P-glycoprotein Limit Sorafenib Brain Accumulation
Lagas, J. S., van Waterschoot, R. A. B., Sparidans, R. W., Wagenaar, E., Beijnen, J. H., & Schinkel, A. H. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0663 · Cited by 185
Collnot, E.-M., Baldes, C., Wempe, M. F., Hyatt, J., Navarro, L., Edgar, K. J., Schaefer, U. F., & Lehr, C.-M. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.005 · Cited by 184
Crounse, R. G. (1961) · Journal of Investigative Dermatology · doi:10.1038/jid.1961.154 · Cited by 184
Kitazaki, T., Oka, M., Nakamura, Y., Tsurutani, J., Doi, S., Yasunaga, M., Takemura, M., Yabuuchi, H., Soda, H., & Kohno, S. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.03.035 · Cited by 182
Platts, J. A., Abraham, M. H., Butina, D., & Hersey, A. (2000) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci990427t · Cited by 181
Clinical Pharmacokinetics of Topotecan
Herben, V. M. M., ten Bokkel Huinink, W. W., & Beijnen, J. H. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631020-00001 · Cited by 180
The Role of Glutathione in the Permeation Enhancing Effect of Thiolated Polymers
Clausen, A. E., Kast, C. E., & Bernkop-Schnürch, A. (2002) · Pharmaceutical Research · doi:10.1023/a:1015345827091 · Cited by 179
Liu, R., & Sharom, F. J. (1996) · Biochemistry · doi:10.1021/bi960823u · Cited by 179
The Mechanism of Action of Multidrug-Resistance-Linked P-Glycoprotein
Sauna, Z. E., Smith, M. M., Müller, M., Kerr, K. M., & Ambudkar, S. V. (2001) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1012875105006 · Cited by 178
Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats
SHIN, S., CHOI, J., & LI, X. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.028 · Cited by 176
Ma, P., Dong, X., Swadley, C. L., Gupte, A., Leggas, M., Ledebur, H. C., & Mumper, R. J. (2009) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2009.1021 · Cited by 174
Jain, S., Rathi, V. V., Jain, A. K., Das, M., & Godugu, C. (2012) · Nanomedicine · doi:10.2217/nnm.12.31 · Cited by 174
Self-citationAn orally delivered small-molecule formulation with antiangiogenic and anticancer activity
Benny, O., Fainaru, O., Adini, A., Cassiola, F., Bazinet, L., Adini, I., Pravda, E., Nahmias, Y., Koirala, S., Corfas, G., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1415 · Cited by 171
Werle, M., & Hoffer, M. H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.011 · Cited by 170
Chung, J. E., Yokoyama, M., Suzuki, K., Aoyagi, T., Sakurai, Y., & Okano, T. (1997) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(97)00015-5 · Cited by 169
Yang, S., Gursoy, R. N., Lambert, G., & Benita, S. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016238.44452.f1 · Cited by 169
Paclitaxel Nanocrystals for Overcoming Multidrug Resistance in Cancer
Liu, Y., Huang, L., & Liu, F. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100012s · Cited by 168
Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin
Yin, Y., Chen, D., Qiao, M., Lu, Z., & Hu, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.09.015 · Cited by 168
Diverse approaches for the enhancement of oral drug bioavailability
Fasinu, P., Pillay, V., Ndesendo, V. M. K., du Toit, L. C., & Choonara, Y. E. (2011) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.750 · Cited by 166
Enhanced Oral Bioavailability of Doxorubicin in a Dendrimer Drug Delivery System
Ke, W., Zhao, Y., Huang, R., Jiang, C., & Pei, Y. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21155 · Cited by 165
Anticancer oral therapy: Emerging related issues
Banna, G. L., Collovà, E., Gebbia, V., Lipari, H., Giuffrida, P., Cavallaro, S., Condorelli, R., Buscarino, C., Tralongo, P., & Ferraù, F. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.04.005 · Cited by 162
Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat
Kisel, M. A., Kulik, L. N., Tsybovsky, I. S., Vlasov, A. P., Vorob'yov, M. S., Kholodova, E. A., & Zabarovskaya, Z. V. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00579-8 · Cited by 161
Yan, Y., Johnston, A. P. R., Dodds, S. J., Kamphuis, M. M. J., Ferguson, C., Parton, R. G., Nice, E. C., Heath, J. K., & Caruso, F. (2010) · ACS Nano · doi:10.1021/nn100173h · Cited by 161
Bansal, T., Akhtar, N., Jaggi, M., Khar, R. K., & Talegaonkar, S. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.010 · Cited by 161
Oral delivery of insulin by using surface coating liposomes
Iwanaga, K., Ono, S., Narioka, K., Morimoto, K., Kakemi, M., Yamashita, S., Nango, M., & Oku, N. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00237-8 · Cited by 160
Troutman, M. D., & Thakker, D. R. (2003) · Pharmaceutical Research · doi:10.1023/a:1025001131513 · Cited by 159
Swarnakar, N. K., Jain, A., Singh, R. P., Godugu, C., Das, M., & Jain, S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.079 · Cited by 159
Self-citationTargeted Cancer Therapy With Novel High Drug-Loading Nanocrystals
Liu, F., Park, J.-Y., Zhang, Y., Conwell, C., Liu, Y., Bathula, S. R., & Huang, L. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22112 · Cited by 159
Singh, A. K., Chaurasiya, A., Awasthi, A., Mishra, G., Asati, D. P., Khar, R. K., & Mukherjee, R. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9281-7 · Cited by 158
Effect of Pluronic P85 on ATPase Activity of Drug Efflux Transporters
Batrakova, E. V., Li, S., Li, Y., Alakhov, V. Y., & Kabanov, A. V. (2004) · Pharmaceutical Research · doi:10.1007/s11095-004-7675-5 · Cited by 158
Oral Delivery of Doxorubicin Using Novel Polyelectrolyte-Stabilized Liposomes (Layersomes)
Jain, S., Patil, S. R., Swarnakar, N. K., & Agrawal, A. K. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300202c · Cited by 158
Self-citationKhandavilli, S., & Panchagnula, R. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700485 · Cited by 158
Conjugated Chitosan as a Novel Platform for Oral Delivery of Paclitaxel
Lee, E., Lee, J., Lee, I., Yu, M., Kim, H., Chae, S. Y., & Jon, S. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800767c · Cited by 157
Agüeros, M., Zabaleta, V., Espuelas, S., Campanero, M. A., & Irache, J. M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.012 · Cited by 156
Preservation of nanostructured lipid carriers (NLC)
Obeidat, W. M., Schwabe, K., Müller, R. H., & Keck, C. M. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.05.001 · Cited by 155
Tsai, Y.-M., Jan, W.-C., Chien, C.-F., Lee, W.-C., Lin, L.-C., & Tsai, T. (2011) · Food Chemistry · doi:10.1016/j.foodchem.2011.01.059 · Cited by 152
Zhang, T., Chen, J., Zhang, Y., Shen, Q., & Pan, W. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.04.005 · Cited by 152
Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded nanosponges
Torne, S. J., Ansari, K. A., Vavia, P. R., Trotta, F., & Cavalli, R. (2010) · Drug Delivery · doi:10.3109/10717541003777233 · Cited by 152
Yao, H.-J., Ju, R.-J., Wang, X., Zhang, Y., Li, R., Yu, Y., Zhang, L., & Lü, W.-L. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.038 · Cited by 151
Effects of Poly(ethylene glycol) on Efflux Transporter Activity in Caco‐2 Cell Monolayers
Hugger, E. D., Audus, K. L., & Borchardt, R. T. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10175 · Cited by 151
Jamal‐Hanjani, M., & Spicer, J. F. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2529 · Cited by 151
Dube, A., Nicolazzo, J. A., & Larson, I. C. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.09.004 · Cited by 150
Dendrimers for Enhanced Drug Solubilization
Svenson, S., & Chauhan, A. S. (2008) · Nanomedicine · doi:10.2217/17435889.3.5.679 · Cited by 149
Bhardwaj, V., Ankola, D. D., Gupta, S., Schneider, M., Lehr, C., & Kumar, M. N. V. R. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9965-4 · Cited by 145
Hu, B., Ting, Y., Yang, X., Tang, W., Zeng, X., & Huang, Q. (2012) · Chemical Communications · doi:10.1039/c2cc17295j · Cited by 144
Understanding the structure and stability of paclitaxel nanocrystals
Deng, J., Huang, L., & Liu, F. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.02.013 · Cited by 143
Application of dendrimer–drug complexation in the enhancement of drug solubility and bioavailability
Jain, N. K., & Gupta, U. D. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.8.1035 · Cited by 142
Bansal, T., Mishra, G., Jaggi, M., Khar, R. K., & Talegaonkar, S. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.12.005 · Cited by 140
Improved Oral Delivery of Paclitaxel Following Administration in Nanoemulsion Formulations
Tiwari, S. B., & Amiji, M. M. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.440 · Cited by 139
Agüeros, M., Ruiz-Gatón, L., Vauthier, C., Bouchemal, K., Espuelas, S., Ponchel, G., & Irache, J. M. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.09.010 · Cited by 139
van Asperen, J., van Tellingen, O., van der Valk, M. A., Rozenhart, M., & Beijnen, J. H. (1998) · PubMed · Cited by 138
Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability
Wu, X., Xu, J., Huang, X., & Wen, C. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2010.489560 · Cited by 137
Ling, G., Zhang, P., Zhang, W., Sun, J., Meng, X., Qin, Y., Deng, Y., & He, Z. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.010 · Cited by 136
Shapira, A., Davidson, I., Avni, N., Assaraf, Y. G., & Livney, Y. D. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.10.022 · Cited by 135
Uptake of drugs into the intestinal lymphatics after oral administration
Porter, C. J. H., & Charman, W. N. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00492-9 · Cited by 135
Gelatin Coated Hybrid Lipid Nanoparticles for Oral Delivery of Amphotericin B
Jain, S., Valvi, P. U., Swarnakar, N. K., & Thanki, K. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300320d · Cited by 134
Self-citationRoger, E., Lagarce, F., & Benoît, J. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.01.021 · Cited by 133
Atyabi, F., Saremi, S., Akhlaghi, S. P., Dinarvand, R., & Ostad, S. N. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s15500 · Cited by 133
M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery
Jepson, M. A., Clark, M. A., & Hirst, B. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.018 · Cited by 130
Mo, Y., & Lim, L. Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.06.024 · Cited by 128
Tumor angiogenesis and novel antiangiogenic strategies
Gordon, M. S., Mendelson, D. S., & Kato, G. (2009) · International Journal of Cancer · doi:10.1002/ijc.25026 · Cited by 127
Hydrotropic polymer micelles containing acrylic acid moieties for oral delivery of paclitaxel
Kim, S., Kim, J. Y., Huh, K. M., Acharya, G. S., & Park, K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.07.004 · Cited by 127
Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis
Kim, W. J., Yockman, J. W., Lee, M., Jeong, J. H., Kim, Y., & Kim, S. W. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.016 · Cited by 126
A Novel Reactive Polymeric Micelle with Aldehyde Groups on Its Surface
Scholz, C., Iijima, M., Nagasaki, Y., & Kataoka, K. (1995) · Macromolecules · doi:10.1021/ma00125a040 · Cited by 126
Yuan, H., Lu, L.-J., Du, Y., & Hu, F. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100289v · Cited by 125
Engineered PLGA Nanoparticles: An Emerging Delivery Tool in Cancer Therapeutics
Jain, A., Das, M., Swarnakar, N. K., & Jain, S. (2011) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v28.i1.10 · Cited by 124
Self-citationZabaleta, V., Ponchel, G., Salman, H. H., Agüeros, M., Vauthier, C., & Irache, J. M. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.04.001 · Cited by 123
Thakkar, H. P., Nangesh, J., Parmar, M. P., & Patel, D. (2011) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.84463 · Cited by 122
A novel folate-modified self-microemulsifying drug delivery system of curcumin for colon targeting
Zhai, G., Zhang, Guo, Yu, Y., Ji, Gao, & Sun (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s27639 · Cited by 119
Molecular Docking of Aromatase Inhibitors
Suvannang, N., Nantasenamat, C., Isarankura‐Na‐Ayudhya, C., & Prachayasittikul, V. (2011) · Molecules · doi:10.3390/molecules16053597 · Cited by 118
Bikádi, Z., Hazai, I., Malik, D., Jemnitz, K., Veres, Z., Hári, P., Ni, Z., Loo, T. W., Clarke, D. M., Hazai, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025815 · Cited by 117
Yan, Y.-D., Kim, J. A., Kwak, M. K., Yoo, B. K., Yong, C. S., & Choi, H. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1179 · Cited by 115
Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer
Chiu, G. N. C., Tan, Liu, Chang, & Lim (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s26538 · Cited by 113
The gastrointestinal stability of lipid nanocapsules
Roger, E., Lagarce, F., & Benoît, J. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.05.069 · Cited by 113
Bromberg, L. E., & Alakhov, V. Y. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00419-4 · Cited by 112
Harrison, M. R., Hahn, N. M., Пили, Р., Oh, W. K., Hammers, H. J., Sweeney, C. J., Kim, K., Perlman, S. B., Arnott, J., Sidor, C. F., et al. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9455-x · Cited by 111
Wong, H. L., Rauth, A. M., Bendayan, R., & Wu, X. Y. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.10.022 · Cited by 109
Hiremath, P. S., Soppimath, K. S., & Betageri, G. V. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.07.008 · Cited by 109
A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers
Ganta, S., Deshpande, D., Korde, A., & Amiji, M. M. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.497971 · Cited by 109
Effect of excipients on breast cancer resistance protein substrate uptake activity
Yamagata, T., Kusuhara, H., Morishita, M., Takayama, K., Benameur, H., & Sugiyama, Y. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.021 · Cited by 108
Kim, B.-Y., Jeong, J. H., Park, K., & Kim, J.-D. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.032 · Cited by 108
Cited by
New developments in liposomal drug delivery
Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600
Chandrakala, V., Aruna, V., & Angajala, G. (2022) · Emergent Materials · doi:10.1007/s42247-021-00335-x · Cited by 768
Bilia, A. R., Guccione, C., Isacchi, B., Righeschi, C., Firenzuoli, F., & Bergonzi, M. C. (2014) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2014/651593 · Cited by 514
RetractedHydrogel-Based Controlled Drug Delivery for Cancer Treatment: A Review
Sun, Z., Song, C., Wang, C., Hu, Y., & Wu, J. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01020 · Cited by 413
Nanotechnology Approaches for Increasing Nutrient Bioavailability
Jafari, S. M., & McClements, D. J. (2017) · Advances in Food and Nutrition Research · doi:10.1016/bs.afnr.2016.12.008 · Cited by 386
Metadata
- Authors
- Thanki, K., Gangwal, R. P., Sangamwar, A. T., & Jain, S.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 170
- Issue
- 1
- Pages
- 15-40
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2003987803
- Cited by
- 499
- References
- 295
- FWCI
- 23.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.